Additionally, the contribution of MUO-related upregulated Transmembrane Serine Protease 2 (TMPRSS2) expression, hyperglycemia, and weakened immune surveillance to the poorer prognosis of COVID-19 in the corresponding patient population are also being in-depth investigated. This evidence concerns the gene TMPRSS2 and Hyperglycemia.